AUPQ026799A0 - Method of increasing protein stability by removing immunoglobulin aggregates - Google Patents

Method of increasing protein stability by removing immunoglobulin aggregates

Info

Publication number
AUPQ026799A0
AUPQ026799A0 AUPQ0267A AUPQ026799A AUPQ026799A0 AU PQ026799 A0 AUPQ026799 A0 AU PQ026799A0 AU PQ0267 A AUPQ0267 A AU PQ0267A AU PQ026799 A AUPQ026799 A AU PQ026799A AU PQ026799 A0 AUPQ026799 A0 AU PQ026799A0
Authority
AU
Australia
Prior art keywords
protein stability
increasing protein
immunoglobulin aggregates
removing immunoglobulin
aggregates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPQ0267A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CSL Ltd
Original Assignee
CSL Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CSL Ltd filed Critical CSL Ltd
Priority to AUPQ0267A priority Critical patent/AUPQ026799A0/en
Publication of AUPQ026799A0 publication Critical patent/AUPQ026799A0/en
Priority to AU43855/00A priority patent/AU4385500A/en
Priority to PCT/AU2000/000433 priority patent/WO2000067789A1/en
Priority to EP00924972A priority patent/EP1176979A4/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39591Stabilisation, fragmentation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
AUPQ0267A 1999-05-10 1999-05-10 Method of increasing protein stability by removing immunoglobulin aggregates Abandoned AUPQ026799A0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AUPQ0267A AUPQ026799A0 (en) 1999-05-10 1999-05-10 Method of increasing protein stability by removing immunoglobulin aggregates
AU43855/00A AU4385500A (en) 1999-05-10 2000-05-10 High concentration immunoglobulin preparation and method for its production
PCT/AU2000/000433 WO2000067789A1 (en) 1999-05-10 2000-05-10 High concentration immunoglobulin preparation and method for its production
EP00924972A EP1176979A4 (en) 1999-05-10 2000-05-10 High concentration immunoglobulin preparation and method for its production

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPQ0267A AUPQ026799A0 (en) 1999-05-10 1999-05-10 Method of increasing protein stability by removing immunoglobulin aggregates

Publications (1)

Publication Number Publication Date
AUPQ026799A0 true AUPQ026799A0 (en) 1999-06-03

Family

ID=3814474

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPQ0267A Abandoned AUPQ026799A0 (en) 1999-05-10 1999-05-10 Method of increasing protein stability by removing immunoglobulin aggregates

Country Status (3)

Country Link
EP (1) EP1176979A4 (en)
AU (1) AUPQ026799A0 (en)
WO (1) WO2000067789A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040033228A1 (en) 2002-08-16 2004-02-19 Hans-Juergen Krause Formulation of human antibodies for treating TNF-alpha associated disorders
JP4586027B2 (en) 2004-01-30 2010-11-24 シャイア ファーマシューティカルズ アイルランド リミテッド Production and purification of recombinant arylsulfatase A
WO2007112757A2 (en) * 2006-04-04 2007-10-11 Zymenex A/S A process for concentration of a polypeptide
EP2142565A4 (en) 2007-03-29 2010-03-31 Abbott Lab Crystalline anti-human il-12 antibodies
US8883146B2 (en) 2007-11-30 2014-11-11 Abbvie Inc. Protein formulations and methods of making same
US20110166332A1 (en) * 2008-09-12 2011-07-07 Ge Healthcare Bio-Sciences Ab Enhanced antibody aggregate removal with capto adhere in the presence of protein-excluded zwitterions
KR101464032B1 (en) * 2009-05-27 2014-11-27 백스터 인터내셔널 인코포레이티드 A method to produce a highly concentrated immunoglobulin preparation for subcutaneous use
EP2729566B1 (en) 2011-07-08 2017-03-15 Shire Human Genetic Therapies, Inc. Methods for purification of arylsulfatase a
SG10201705668XA (en) 2012-09-07 2017-08-30 Coherus Biosciences Inc Stable aqueous formulations of adalimumab
AU2014205441B2 (en) 2013-01-09 2019-12-12 Takeda Pharmaceutical Company Limited Methods for purification of arylsulfatase A
US11229702B1 (en) 2015-10-28 2022-01-25 Coherus Biosciences, Inc. High concentration formulations of adalimumab
US11071782B2 (en) 2016-04-20 2021-07-27 Coherus Biosciences, Inc. Method of filling a container with no headspace

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3310150A1 (en) * 1983-03-21 1984-09-27 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München METHOD FOR PRODUCING A IGG IMMUNOGLOBULIN SOLUTION WITHOUT SIDE EFFECTS FOR THE INTRAVENOUS APPLICATION
US4597966A (en) * 1985-01-09 1986-07-01 Ortho Diagnostic Systems, Inc. Histidine stabilized immunoglobulin and method of preparation
CA1310267C (en) * 1986-07-09 1992-11-17 Yutaka Hirao Process for heat treating chemically unmodified _-globulin
DE3641115A1 (en) * 1986-12-02 1988-06-16 Lentia Gmbh METHOD FOR PRODUCING AN INTRAVENOUS APPLICABLE AND STABLE IN LIQUID FORM IMMUNOGLOBULINS
US5656730A (en) * 1995-04-07 1997-08-12 Enzon, Inc. Stabilized monomeric protein compositions
AU3429797A (en) * 1996-07-18 1998-02-10 Csl Limited Pasteurization of immunoglobulin solutions
GB9705810D0 (en) * 1997-03-20 1997-05-07 Common Services Agency Intravenous immune globulin
BR9911131A (en) * 1998-06-09 2001-03-06 Statens Seruminstitut Process for producing immunoglobulins for intravenous administration and other immunoglobulin products

Also Published As

Publication number Publication date
EP1176979A1 (en) 2002-02-06
WO2000067789A1 (en) 2000-11-16
EP1176979A4 (en) 2005-05-04

Similar Documents

Publication Publication Date Title
AU2001294175A1 (en) Method of purifying antibody
AU2001240115A1 (en) Method for the preparation of tetrahydrobenzothiepines
AU5005700A (en) Method for the manufacture of toothpaste
AU2002353458A1 (en) Method for the preparation of aggregates
AUPQ026799A0 (en) Method of increasing protein stability by removing immunoglobulin aggregates
AU2002353310A1 (en) Method for the preparation of nucleic acids
AU1683200A (en) Method for improving gelling properties of protein
AU4552200A (en) Method of treating psychotic disorders
AU2354800A (en) Method of protein removal
AU2001294258A1 (en) Method of purifying plavastatin
AU2001231086A1 (en) Method of affinity purifying proteins using modified bis-arsenical fluorescein
AU2376001A (en) Method for the manufacture of olefins
AU2169201A (en) Method for the isolation of hydrophobic proteins
AUPP385598A0 (en) Purification of antibodies
AU2001287695A1 (en) Method for purifying recombinant proteins expressed as insoluble aggregates
AU4441200A (en) Method for transforming chords
AU2001260220A1 (en) Method for modification of proteins by transglutaminase
AU1683100A (en) Method for improving solubility of protein
AU5977599A (en) Method for the rectificative separation of chlorosilanes
AU6300500A (en) Method for identifying interacting proteins
AU2001253092A1 (en) Method for detection of truncated proteins
AU1478201A (en) Improved method of immunization
AU4575800A (en) Purification method by affinity
AU1784701A (en) Method of treating neuroblastoma
AU4914600A (en) Method for treating tnf-receptor type-2-induced diseases

Legal Events

Date Code Title Description
NAA1 Application designating australia and claiming priority from australian document

Ref document number: 4385500

Country of ref document: AU